SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062091
Filing Date
2023-11-09
Accepted
2023-11-09 16:19:09
Documents
58
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nktx-20230930.htm   iXBRL 10-Q 2567306
2 EX-31.1 nktx-ex31_1.htm EX-31.1 18972
3 EX-31.2 nktx-ex31_2.htm EX-31.2 18447
4 EX-32 nktx-ex32.htm EX-32 17948
  Complete submission text file 0000950170-23-062091.txt   8177770

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nktx-20230930_cal.xml EX-101.CAL 44994
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktx-20230930_lab.xml EX-101.LAB 400884
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktx-20230930_pre.xml EX-101.PRE 287627
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktx-20230930.xsd EX-101.SCH 41251
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nktx-20230930_def.xml EX-101.DEF 170895
52 EXTRACTED XBRL INSTANCE DOCUMENT nktx-20230930_htm.xml XML 1390918
Mailing Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 (925) 407-1049
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39370 | Film No.: 231392781
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences